XML 33 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table reconciles cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
September 30,
 20202019
(In millions)
Cash and cash equivalents$3,196 $2,679 
Restricted cash and cash equivalents70 55 
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$3,266 $2,734 
Restricted Cash and Cash Equivalents The following table reconciles cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
September 30,
 20202019
(In millions)
Cash and cash equivalents$3,196 $2,679 
Restricted cash and cash equivalents70 55 
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$3,266 $2,734 
Amounts Due to Government Agencies
September 30,
2020
December 31,
2019
(In millions)
Medicaid program:
Minimum MLR and profit sharing$136 $92 
Other83 95 
Medicare program:
Risk adjustment and Part D risk sharing38 14 
Minimum MLR and profit sharing 35 36 
Other30 21 
Marketplace program:
Risk adjustment265 368 
Minimum MLR33 15 
Other20 23 
Total amounts due government agencies$640 $664 
Quality Incentive Premium Revenue Recognized
The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the periods presented and prior periods.
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
(In millions)
Maximum available quality incentive premium - current period
$69 $47 $195 $138 
Quality incentive premium revenue recognized in current period:
Earned current period$63 $46 $180 $109 
Earned prior periods19 23 35 
Total$82 $51 $203 144 
Quality incentive premium revenue recognized as a percentage of total premium revenue
1.7 %1.2 %1.5 %1.2 %
Schedule of Receivables
September 30,
2020
December 31,
2019
(In millions)
Government receivables$1,180 $1,056 
Pharmacy rebate receivables175 150 
Health insurer fee reimbursement receivables180 
Other240 195 
Total$1,775 $1,406